Recent Business Highlights

Our Quality Journey WE ARE COMMITTED TO EXCELLENCE IN QUALITY AND TO BEING THE BEST IN THE INDUSTRY U.S. FDA Audit Updates Sites Previously on Warning Letter CTO 5: Three observations in audit - Received EIR CTO 6: Received EIR: compliance pending FTO 7 Sterile Plant: Received EIR: compliance pending, anticipating re-audit in H2 2018 Other Sites CTO SEZ: Concluded with zero observations CTO 3: Concluded with five observations CTO 1: Concluded with four observations FTO 3 Bachupally: Received EIR Mirfield: Concluded with three observations Mexico: Concluded with zero observations CPS Technology Development Center: Received EIR FTO SEZ PU-01 & 02: Received EIR pam-pac EKSON 2000 000 690 000 20 220

View entire presentation